Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02539706Completed
Open-label trial of rocuronium in neuromuscular blockade (NMB), sponsored by Aydın Adnan Menderes University. Primary endpoint: Pain measure. Started Jan 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02539706.